High Note Wealth’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22
Closed -$3.6K 990
2025
Q4
$3.6K Buy
+22
New +$3.45K ﹤0.01% 628
2025
Q3
Sell
-26
Closed -$3.23K 971
2025
Q2
$3.23K Buy
26
+2
+8% +$255 ﹤0.01% 596
2025
Q1
$3.05K Buy
24
+11
+85% +$1.69K ﹤0.01% 586
2024
Q4
$1.87K Buy
+13
New +$1.86K ﹤0.01% 698

Other funds holding RGEN

High Note Wealth's RGEN Position: Q1 2026 in Review

High Note Wealth sold out of Repligen (RGEN) in Q1 2026, closing a stake of 22 shares — an estimated $3.6K sold.

High Note Wealth first reported a position in RGEN in Q4 2024 and held it in 4 quarters. The position peaked at $3.6K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • High Note Wealth reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • High Note Wealth sold 22 Repligen shares in Q1 2026, an estimated $3.6K.
  • High Note Wealth first reported a position in Repligen in Q4 2024 and held it in 4 quarters.
  • High Note Wealth's Repligen position peaked at $3.6K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on High Note Wealth's 13F filing for Q1 2026, filed 11 May 2026.